MPEG LA Initiative to Address CRISPR Licensing
World licensing leader MPEG LA, LLC announced today an initiative to address the need for an efficient one-stop license alternative around CRISPR, a breakthrough technology that enables cellular DNA to be edited quickly and inexpensively. Some CRISPR patents are currently the subject of an interference proceeding (No. 106048 ) among various patent holders and applicants before the US Patent and Trademark Office.
“CRISPR’s wide range of potential applications in medicine and agriculture, and the steadily increasing volume of intellectual property in the field, point to the need for a one-stop licensing platform to reduce litigation risk and provide efficiency, transparency and predictability to scientists and businesses worldwide,” said MPEG LA President and CEO Larry Horn. “Our worldwide licensing infrastructure, trusted reputation for independence, experience, impartiality and results with patent pools, and relationships with industry and academia, including life sciences, position MPEG LA to deliver a licensing solution for the life sciences market as it did with digital video for the consumer electronics market.”
“We are mapping the CRISPR Cas-9 patent landscape as a tool for identifying essential patents to be licensed together in a single transaction for various genome engineering applications on a worldwide basis,” said Kristin Neuman, MPEG LA Executive Director of Biotechnology Licensing, “and will incorporate other genomic engineering technologies as they emerge.”
MPEG LA welcomes the participation of the CRISPR community. A mapping reference model defining the license coverage that will free developers to focus on creating quality-of-life enhancing products while compensating inventors is expected to be available soon. Updates may be found on MPEG LA’s CRISPR page at http://www.mpegla.com/main/pid/CRISPR/default.aspx . For more information, please email firstname.lastname@example.org .
MPEG LA, LLC
MPEG LA is the world’s leading provider of one-stop licenses for standards and other technology platforms. Starting in the 1990s, it pioneered the modern-day patent pool helping to produce the most widely used standards in consumer electronics history. MPEG LA has operated licensing programs for a variety of technologies consisting of more than 13,000 patents in 82 countries with some 230 patent holders and more than 6,000 licensees. By assisting users with implementation of their technology choices, MPEG LA offers licensing solutions that provide access to fundamental intellectual property, freedom to operate, reduced litigation risk and predictability in the business planning process. In turn, this enables inventors, research institutions and other technology owners to monetize and speed market adoption of their assets to a worldwide market while substantially reducing the cost of licensing. For more information, go to www.mpegla.com .
MPEG LA, LLC
Tom O’Reilly, 303-200-1710
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
BOEHRINGER-INGELHEIM11.12.2017 14:02 | pressemeddelelse
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
NY-VALENCE-GROUP11.12.2017 13:49 | pressemeddelelse
Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses
SMITH-&-NEPHEW11.12.2017 11:20 | pressemeddelelse
Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care
UAE-FNC11.12.2017 10:43 | pressemeddelelse
Dr Amal Al Qubaisi Wins Parliamentarian Excellence Award as Best President of Arab Parliament
GA-CELLTRION-HEALTHCARE11.12.2017 09:02 | pressemeddelelse
Top UK university hospital unveils data that support the use of rapid infusion for Truxima® (CT-P10, biosimilar rituximab) in patients with advanced-stage follicular lymphoma
DIMOCO-EUROPE11.12.2017 09:02 | pressemeddelelse
Financial Market Regulator Grants EU Payment License to DIMOCO Payment Services
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum